Toshiro Kawakita

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

Tomoko Nanri, Naofumi Matsuno, Toshiro Kawakita et al. · Leukemia · 2005 · 93 citations

Hematological Malignancy, Tumor Biology, Radiation Oncology +11

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Domenico Russo, Michael Henry Schmitt, Sylvain Pilorge et al. · The Lancet Haematology · 2023 · 82 citations

Cell Therapy, Cytomegalovirus Infection, Transplantation +5

Digenic mutations in <i>ALDH2</i> and <i>ADH5</i> impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome

Yasuyoshi Oka, Motoharu Hamada, Yuka Nakazawa et al. · Science Advances · 2020 · 78 citations · Full text

Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases

Shunsuke Mori, Michihiro Hidaka, Toshiro Kawakita et al. · PLoS ONE · 2016 · 64 citations · Full text

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

Takaaki Konuma, Shohei Mizuno, Tadakazu Kondo et al. · Blood Cancer Journal · 2022 · 37 citations · Full text